FDA guidance
Additional Recommendations for Donor Screening With a Licensed Test for HIV-1 Antigen…
FDA guidance · Final · issued Mar 14, 1996
Key facts
| Title | Additional Recommendations for Donor Screening With a Licensed Test for HIV-1 Antigen: Memorandum to Registered Blood and Plasma Establishments |
|---|---|
| Status | Final |
| Issue date | Mar 14, 1996 |
| Center | Center for Biologics Evaluation and Research |
| Issuing office | Center for Biologics Evaluation and Research |
| Communication type | Memorandum |
| Regulated product | Biologics |
| Docket number | FDA-2022-D-0499 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents